Abstract
Impulsivity involves irresistibility in execution of actions and is prominent in medication condition of Parkinson’s disease (PD) patients. In this chapter, we model a probabilistic reversal learning task in PD patients with and without impulse control disorder (ICD) to understand the basis of their neural circuitry responsible for displaying ICD in PD condition. The proposed model is of the basal ganglia (BG) action selection dynamics, and it predicts the dysfunction of both dopaminergic (DA) and serotonergic (5HT) neuromodulator systems to account for the experimental results. Furthermore, the BG is modeled after utility function framework with DA controlling reward prediction and 5HT controlling the loss and risk prediction, respectively. The striatal model has three pools of medium spiny neurons (MSNs) including those with D1 receptor (R) alone, D2R alone, and co-expressing D1R–D2R neurons. Some significant results modeled are increased reward sensitivity during ON medication and an increased punishment sensitivity during OFF medication in patients. The lower reaction times (RT) in ICD subjects compared to that of the non-ICD category of the PD ON patients are also explained. Other modeling predictions include a significant decrease in the sensitivity to loss and risk in the ICD patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahlskog, J. E. (2010). Think before you leap Donepezil reduces falls? Neurology, 75(14), 1226–1227.
Averbeck, B., O’Sullivan, S., & Djamshidian, A. (2014). Impulsive and compulsive behaviors in Parkinson’s disease. Annual Review of Clinical Psychology, 10, 553–580.
Balasubramani, P. P., Chakravarthy, V. S., Ali, M., Ravindran, B., & Moustafa, A. A. (2015). Identifying the basal ganglia network model markers for medication-induced impulsivity in Parkinson’s disease patients. PLoS ONE, 10(6), e0127542.
Bedard, C., Wallman, M. J., Pourcher, E., Gould, P. V., Parent, A., & Parent, M. (2011). Serotonin and dopamine striatal innervation in Parkinson’s disease and Huntington’s chorea. Parkinsonism and Related Disorders, 17(8), 593–598. https://doi.org/10.1016/j.parkreldis.2011.05.012.
Bodi, N., Keri, S., Nagy, H., Moustafa, A., Myers, C. E., Daw, N., … Gluck, M. A. (2009). Reward-learning and the novelty-seeking personality: a between- and within-subjects study of the effects of dopamine agonists on young Parkinson’s patients. Brain, 132(Pt 9), 2385–2395. https://doi.org/10.1093/brain/awp094.
Bugalho, P., & Oliveira-Maia, A. J. (2013). Impulse control disorders in Parkinson’s disease: Crossroads between neurology, psychiatry and neuroscience. Behavioural Neurology, 27(4), 547–557.
Dalley, J. W., Everitt, B. J., & Robbins, T. W. (2011). Impulsivity, compulsivity, and top-down cognitive control. Neuron, 69(4), 680–694.
Dalley, J. W., Mar, A. C., Economidou, D., & Robbins, T. W. (2008). Neurobehavioral mechanisms of impulsivity: Fronto-striatal systems and functional neurochemistry. Pharmacology, Biochemistry and Behavior, 90(2), 250–260.
Djamshidian, A., Averbeck, B. B., Lees, A. J., & O’Sullivan, S. S. (2011). Clinical aspects of impulsive compulsive behaviours in Parkinson’s disease. Journal of the Neurological Sciences, 310(1), 183–188.
Dougherty, D. M., Mathias, C. W., Marsh, D. M., & Jagar, A. A. (2005). Laboratory behavioral measures of impulsivity. Behavior Research Methods, 37(1), 82–90.
Doya, K. (2002). Metalearning and neuromodulation. Neural Network, 15(4–6), 495–506.
Evans, A. H., Pavese, N., Lawrence, A. D., Tai, Y. F., Appel, S., Doder, M., … Piccini, P. (2006). Compulsive drug use linked to sensitized ventral striatal dopamine transmission. Annals of Neurology, 59(5), 852–858.
Evenden, J. L. (1999). Varieties of impulsivity. Psychopharmacology (Berl), 146(4), 348–361.
Fahn, S., Libsch, L. R., & Cutler, R. W. (1971). Monoamines in the human neostriatum: Topographic distribution in normals and in Parkinson’s disease and their role in akinesia, rigidity, chorea, and tremor. Journal of the Neurological Sciences, 14(4), 427–455.
Fahn, S., Snider, S., Prasad, A. L., Lane, E., & Makadon, H. (1975). Normalization of brain serotonin by L-tryptophan in levodopa-treated rats. Neurology, 25(9), 861–865.
Frank, M. J. (2005). Dynamic dopamine modulation in the basal ganglia: A neurocomputational account of cognitive deficits in medicated and nonmedicated Parkinsonism. Journal of Cognitive Neuroscience, 17(1), 51–72. https://doi.org/10.1162/0898929052880093.
Frank, M. J., Samanta, J., Moustafa, A. A., & Sherman, S. J. (2007a). Hold your horses: Impulsivity, deep brain stimulation, and medication in parkinsonism. Science, 318(5854), 1309–1312. https://doi.org/10.1126/science.1146157.
Frank, M. J., Scheres, A., & Sherman, S. J. (2007b). Understanding decision-making deficits in neurological conditions: Insights from models of natural action selection. Philosophical Transactions of the Royal Society B: Biological Sciences, 362(1485), 1641–1654.
Halliday, G. M., Blumbergs, P. C., Cotton, R. G., Blessing, W. W., & Geffen, L. B. (1990). Loss of brainstem serotonin- and substance P-containing neurons in Parkinson’s disease. Brain Research, 510(1), 104–107.
Nombela, C., Rittman, T., Robbins, T. W., & Rowe, J. B. (2014). Multiple modes of impulsivity in Parkinson’s disease. PLoS ONE, 9(1), e85747.
Piray, P., Zeighami, Y., Bahrami, F., Eissa, A. M., Hewedi, D. H., & Moustafa, A. A. (2014). Impulse control disorders in Parkinson’s disease are associated with dysfunction in stimulus valuation but not action valuation. The Journal of Neuroscience, 34(23), 7814–7824.
Ray, N., Antonelli, F., & Strafella, A. P. (2011). Imaging impulsivity in Parkinson’s disease and the contribution of the subthalamic nucleus. Parkinson’s Dis. 2011:594860. doi: 10.4061/2011/594860.
Reed, M. C., Nijhout, H. F., & Best, J. A. (2012). Mathematical insights into the effects of levodopa. Frontiers in integrative neuroscience, 6, 21. doi: 10.3389/fnint.2012.00021
Steeves, T., Miyasaki, J., Zurowski, M., Lang, A., Pellecchia, G., Van Eimeren, T., … Strafella, A. (2009). Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain, 132(5), 1376–1385.
Tan, A., Salgado, M., & Fahn, S. (1996). Rapid eye movement sleep behavior disorder preceding Parkinson’s disease with therapeutic response to levodopa. Movement Disorders, 11(2), 214–216.
Tanaka, S. C., Schweighofer, N., Asahi, S., Shishida, K., Okamoto, Y., Yamawaki, S., et al. (2007). Serotonin differentially regulates short- and long-term prediction of rewards in the ventral and dorsal striatum. PLoS ONE, 2(12), e1333. https://doi.org/10.1371/journal.pone.0001333.
Wylie, S. A., Ridderinkhof, K. R., Bashore, T. R., & van den Wildenberg, W. P. (2010). The effect of Parkinson’s disease on the dynamics of on-line and proactive cognitive control during action selection. Journal of Cognitive Neuroscience, 22(9), 2058–2073.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Balasubramani, P.P., Srinivasa Chakravarthy, V., Ravindran, B., Moustafa, A.A. (2018). Modeling Serotonin’s Contributions to Basal Ganglia Dynamics in Parkinson’s Disease with Impulse Control Disorders. In: Computational Neuroscience Models of the Basal Ganglia. Cognitive Science and Technology. Springer, Singapore. https://doi.org/10.1007/978-981-10-8494-2_13
Download citation
DOI: https://doi.org/10.1007/978-981-10-8494-2_13
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-8493-5
Online ISBN: 978-981-10-8494-2
eBook Packages: EngineeringEngineering (R0)